T37078 |
VEGFR-2-IN-6
|
|
VEGFR
|
|
VEGFR-2-IN-6 (WO 02/059110, example 64) is a potent inhibitor of VEGFR2, a crucial receptor involved in the regulation o... |
T2056 |
VEGFR-2-IN-5
|
UNC0064-12,2,4-Pyrimidinediamine with linker,2, 4-Pyrimidinediamine with linker |
VEGFR
|
|
UNC0064-12 is a patent compound in WO2013055780A1, multikinase inhibitor and has a -NH2 terminal linker for further synt... |
T72924 |
VEGFR-3-IN-1
|
|
VEGFR
|
|
VEGFR-3-IN-1 is a novel potent and selective VEGFR3 inhibitor with an IC50 of 110.4 nM.VEGFR-3-IN-1 possesses antitumor ... |
T23504 |
VEGFR-IN-1
|
VEGFR Tyrosine Kinase Inhibitor II |
Others
|
|
VEGFR inhibitor |
T68526 |
VEGFR-IN-V
|
|
|
|
VEGFR-IN-V is a potent, vascular endothelial growth factor receptor-2 (VEGFR-2) tyrosine kinase inhibitor. |
T40581 |
TIE-2/VEGFR-2 kinase-IN-2
|
|
|
|
TIE-2/VEGFR-2 kinase-IN-2 is a powerful inhibitor of both VEGFR2 and Tie-2 kinases, displaying noteworthy pIC 50 values ... |
T10123 |
VEGFR-2-IN-9
|
KDR-in-4 |
VEGFR
|
|
KDR-in-4 is an effective inhibitor of kinase insert domain-containing receptor (KDR/VEGFR2) (IC50: 7 nM). |
T63112 |
VEGFR-IN-3
|
|
|
|
VEGFR-IN-3 (compound 3f) is a VEGFR inhibitor. VEGFR-IN-3 inhibits OVCAR-4 and MDA-MB-468 cancer cells growth with IC 50... |
T63822 |
VEGFR-2-IN-22
|
|
|
|
VEGFR-2-IN-22 (Compound 25) is an inhibitor of VEGFR-2 and β-tubulin polymerization with an IC50=19.82 nM for VEGFR-2. V... |
T63804 |
VEGFR-2-IN-28
|
|
|
|
VEGFR-2-IN-28 is a potent inhibitor of VEGFR-2 (IC50: 0.83 μM). VEGFR-2-IN-28 induces apoptosis and exhibits antitumor e... |
T62314 |
VEGFR-2-IN-25
|
|
|
|
VEGFR-2-IN-25 (compound 5d) is a potent inhibitor of VEGFR-2 (IC50: 12.1 nM). |
T63002 |
VEGFR-2-IN-15
|
|
|
|
VEGFR-2-IN-15 (Compound 14b) is a potent inhibitor of VEGFR-2. VEGFR-2-IN-15 inhibits the growth of HepG2 cells in the P... |
T62763 |
VEGFR-2-IN-12
|
|
|
|
VEGFR-2-IN-12 (compound 6g), a 2-oxoquinoxalinyl-1,2,4-triazole, is a potent inhibitor of VEGFR-2 (IC50: 0.037 μM). VEGF... |
T61861 |
VEGFR-2-IN-20
|
|
|
|
VEGFR-2-IN-20 (Compound 7) is a highly effective VEGFR inhibitor with significant potential for cancer research [1]. |
T64060 |
VEGFR-2-IN-21
|
|
|
|
VEGFR-2-IN-21 is a potent inhibitor of VEGFR-2 (IC50: 0.10 μM) and exhibits anticancer effects. |
T62796 |
VEGFR-2-IN-13
|
|
|
|
VEGFR-2-IN-13 (Compound 19a) is a potent VEGFR-2 inhibitor (IC50: 3.4 nM). vEGFR-2-IN-13 arrests the HepG2 cell cycle in... |
T72890 |
VEGFR-2-IN-30
|
|
|
|
VEGFR-2-IN-30 is a VEGFR-2 inhibitor ( IC 50 : 66 nM). VEGFR-2-IN-30 also inhibits PDGFR , EGFR and FGFR1 with IC 50 s o... |
T63722 |
VEGFR-2-IN-24
|
|
|
|
VEGFR-2-IN-24 is a potent inhibitor of VEGFR-2 (IC50: 0.22 μM) and can be used to study tumors. |
T62071 |
VEGFR-2-IN-16
|
|
|
|
VEGFR-2-IN-16 (Compound 15b) is a potent inhibitor of VEGFR-2 (IC50: 86.36 nM) that exhibits antitumour effects. |
T62901 |
VEGFR-2-IN-27
|
|
|
|
VEGFR-2-IN-27 (compound 7a) is a potent inhibitor of VEGFR-2 (IC50: 14.8 nM) and can be used in anticancer studies. |